IMARC Group, a leading market research company, has recently releases report titled “India Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the India generic injectables market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights
How big is the India generic injectables market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.4 Billion |
| Market Forecast in 2028 | US$ 4.9 Billion |
| Growth rate (2023 to 2028) | CAGR of 12.4% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is India generic injectables?
Generic injectables represent alternative drugs that are bio-equivalent of their branded counterparts in terms of strength, quality, effectiveness, active ingredients, intended use, dosage, etc. In addition to this, as compared to innovator drugs, they offer maximized patient compliance, reduced frequency of drug delivery, limited price erosion, higher profitability for manufacturers, etc. Consequently, generic injectables are extensively utilized to treat several life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, respiratory infections, etc. Request Free Sample Report: https://www.imarcgroup.com/india-generic-injectables-market/requestsampleWhat are the growth prospects and trends in the India generic injectables industry?
The expanding geriatric population who are susceptible to developing numerous medical ailments, including septicemia, influenza, pneumonia, etc., is among the key factors stimulating the India generic injectables market. Moreover, the increasing occurrence of chronic disorders, on account of the growing pollution levels and hectic schedules, changing dietary patterns, and the sedentary lifestyles of individuals, is acting as another significant growth-inducing factor. Besides this, the launch of favorable policies undertaken by government bodies in India to support leading manufacturers and sellers is catalyzing the market growth. Furthermore, various technological advancements in drug delivery systems, such as the introduction of self-injection devices, are also propelling the market growth across the country. Apart from this, the rising number of health insurance companies and the expiry of patents of branded drugs are further augmenting the market growth. Additionally, the development of 3D printing technology by key market players that helps in producing these medicines with varying release dates and tastes and continuous improvements in healthcare facilities are anticipated to fuel the India generic injectables market over the forecasted period.What is included in market segmentation?
The report has segmented the market into the following categories: Breakup by Therapeutic Area:- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral Nutrition
- Cardiovascular
- Vials
- Ampoules
- Premix
- Prefilled Syringes
- Hospitals
- Retail Pharmacy
- North India
- West and Central India
- South India
- East India